Trial Profile

Safety and Effectiveness of the UV-X System for Corneal Collagen Cross-Linking in Eyes With Progressive Keratoconus

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 22 Apr 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Riboflavin (Primary)
Indications Keratoconus
Focus Therapeutic Use
Sponsors Avedro

Most Recent Events

19 Jul 2016 According to an Avedro media release, the US FDA has approved Photrexa Viscous, Photrexa and KXL system used in corneal collagen cross-linking for the treatment of corneal ectasia following refractive surgery based on data from this and two other phase III trials.
06 Jul 2016 The study design has changed from cross-over assignment to parallel assignment.
12 Jun 2014 New trial record

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com